The At-home Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
ALSO READ :
Market segmentation
At-home Genetic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Screening
PGD
Relationship testing
Market segment by Application, can be divided into
Online
Offline
Market segment by players, this report covers
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
ALSO READ :
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
ALSO READ :
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
ALSO READ :
Table of Contents :
1 Market Overview
1.1 Product Overview and Scope of At-home Genetic Testing
1.2 Classification of At-home Genetic Testing by Type
1.2.1 Overview: Global At-home Genetic Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global At-home Genetic Testing Revenue Market Share by Type in 2020
1.2.3 Diagnostic Screening
1.2.4 PGD
1.2.5 Relationship testing
1.3 Global At-home Genetic Testing Market by Application
1.3.1 Overview: Global At-home Genetic Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Online
1.3.3 Offline
1.4 Global At-home Genetic Testing Market Size & Forecast
1.5 Global At-home Genetic Testing Market Size and Forecast by Region
1.5.1 Global At-home Genetic Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global At-home Genetic Testing Market Size by Region, (2016-2021)
1.5.3 North America At-home Genetic Testing Market Size and Prospect (2016-2026)
1.5.4 Europe At-home Genetic Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific At-home Genetic Testing Market Size and Prospect (2016-2026)
1.5.6 South America At-home Genetic Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa At-home Genetic Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 At-home Genetic Testing Market Drivers
1.6.2 At-home Genetic Testing Market Restraints
1.6.3 At-home Genetic Testing Trends Analysis
ALSO READ :
2 Company Profiles
2.1 23andMe
2.1.1 23andMe Details
2.1.2 23andMe Major Business
2.1.3 23andMe At-home Genetic Testing Product and Solutions
2.1.4 23andMe At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 23andMe Recent Developments and Future Plans
2.2 MyHeritage
2.2.1 MyHeritage Details
2.2.2 MyHeritage Major Business
2.2.3 MyHeritage At-home Genetic Testing Product and Solutions
2.2.4 MyHeritage At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 MyHeritage Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp At-home Genetic Testing Product and Solutions
2.3.4 LabCorp At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics At-home Genetic Testing Product and Solutions
2.4.4 Myriad Genetics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Ancestry.com
2.5.1 Ancestry.com Details
2.5.2 Ancestry.com Major Business
2.5.3 Ancestry.com At-home Genetic Testing Product and Solutions
2.5.4 Ancestry.com At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Ancestry.com Recent Developments and Future Plans
2.6 Quest Diagnostics
2.6.1 Quest Diagnostics Details
2.6.2 Quest Diagnostics Major Business
2.6.3 Quest Diagnostics At-home Genetic Testing Product and Solutions
2.6.4 Quest Diagnostics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Quest Diagnostics Recent Developments and Future Plans
2.7 Gene By Gene
2.7.1 Gene By Gene Details
2.7.2 Gene By Gene Major Business
2.7.3 Gene By Gene At-home Genetic Testing Product and Solutions
2.7.4 Gene By Gene At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Gene By Gene Recent Developments and Future Plans
2.8 DNA Diagnostics Center
2.8.1 DNA Diagnostics Center Details
2.8.2 DNA Diagnostics Center Major Business
2.8.3 DNA Diagnostics Center At-home Genetic Testing Product and Solutions
2.8.4 DNA Diagnostics Center At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 DNA Diagnostics Center Recent Developments and Future Plans
2.9 Invitae
2.9.1 Invitae Details
2.9.2 Invitae Major Business
2.9.3 Invitae At-home Genetic Testing Product and Solutions
2.9.4 Invitae At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Invitae Recent Developments and Future Plans
2.10 IntelliGenetics
2.10.1 IntelliGenetics Details
2.10.2 IntelliGenetics Major Business
2.10.3 IntelliGenetics At-home Genetic Testing Product and Solutions
2.10.4 IntelliGenetics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 IntelliGenetics Recent Developments and Future Plans
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business
2.11.3 Ambry Genetics At-home Genetic Testing Product and Solutions
2.11.4 Ambry Genetics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Ambry Genetics Recent Developments and Future Plans
2.12 Living DNA
2.12.1 Living DNA Details
2.12.2 Living DNA Major Business
2.12.3 Living DNA At-home Genetic Testing Product and Solutions
2.12.4 Living DNA At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Living DNA Recent Developments and Future Plans
2.13 EasyDNA
2.13.1 EasyDNA Details
2.13.2 EasyDNA Major Business
2.13.3 EasyDNA At-home Genetic Testing Product and Solutions
2.13.4 EasyDNA At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 EasyDNA Recent Developments and Future Plans
2.14 Pathway Genomics
2.14.1 Pathway Genomics Details
2.14.2 Pathway Genomics Major Business
2.14.3 Pathway Genomics At-home Genetic Testing Product and Solutions
2.14.4 Pathway Genomics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Pathway Genomics Recent Developments and Future Plans
2.15 Centrillion Technology
2.15.1 Centrillion Technology Details
2.15.2 Centrillion Technology Major Business
2.15.3 Centrillion Technology At-home Genetic Testing Product and Solutions
2.15.4 Centrillion Technology At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Centrillion Technology Recent Developments and Future Plans
2.16 Xcode
2.16.1 Xcode Details
2.16.2 Xcode Major Business
2.16.3 Xcode At-home Genetic Testing Product and Solutions
2.16.4 Xcode At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Xcode Recent Developments and Future Plans
2.17 Color Genomics
2.17.1 Color Genomics Details
2.17.2 Color Genomics Major Business
2.17.3 Color Genomics At-home Genetic Testing Product and Solutions
2.17.4 Color Genomics At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Color Genomics Recent Developments and Future Plans
2.18 Anglia DNA Services
2.18.1 Anglia DNA Services Details
2.18.2 Anglia DNA Services Major Business
2.18.3 Anglia DNA Services At-home Genetic Testing Product and Solutions
2.18.4 Anglia DNA Services At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Anglia DNA Services Recent Developments and Future Plans
2.19 African Ancestry
2.19.1 African Ancestry Details
2.19.2 African Ancestry Major Business
2.19.3 African Ancestry At-home Genetic Testing Product and Solutions
2.19.4 African Ancestry At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 African Ancestry Recent Developments and Future Plans
2.20 Canadian DNA Services
2.20.1 Canadian DNA Services Details
2.20.2 Canadian DNA Services Major Business
2.20.3 Canadian DNA Services At-home Genetic Testing Product and Solutions
2.20.4 Canadian DNA Services At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Canadian DNA Services Recent Developments and Future Plans
2.21 DNA Family Check
2.21.1 DNA Family Check Details
2.21.2 DNA Family Check Major Business
2.21.3 DNA Family Check At-home Genetic Testing Product and Solutions
2.21.4 DNA Family Check At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 DNA Family Check Recent Developments and Future Plans
2.22 Alpha Biolaboratories
2.22.1 Alpha Biolaboratories Details
2.22.2 Alpha Biolaboratories Major Business
2.22.3 Alpha Biolaboratories At-home Genetic Testing Product and Solutions
2.22.4 Alpha Biolaboratories At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Alpha Biolaboratories Recent Developments and Future Plans
2.23 Test Me DNA
2.23.1 Test Me DNA Details
2.23.2 Test Me DNA Major Business
2.23.3 Test Me DNA At-home Genetic Testing Product and Solutions
2.23.4 Test Me DNA At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Test Me DNA Recent Developments and Future Plans
2.24 23 Mofang
2.24.1 23 Mofang Details
2.24.2 23 Mofang Major Business
2.24.3 23 Mofang At-home Genetic Testing Product and Solutions
2.24.4 23 Mofang At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 23 Mofang Recent Developments and Future Plans
2.25 Genetic Health
2.25.1 Genetic Health Details
2.25.2 Genetic Health Major Business
2.25.3 Genetic Health At-home Genetic Testing Product and Solutions
2.25.4 Genetic Health At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 Genetic Health Recent Developments and Future Plans
2.26 DNA Services of America
2.26.1 DNA Services of America Details
2.26.2 DNA Services of America Major Business
2.26.3 DNA Services of America At-home Genetic Testing Product and Solutions
2.26.4 DNA Services of America At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.26.5 DNA Services of America Recent Developments and Future Plans
2.27 Shuwen Health Sciences
2.27.1 Shuwen Health Sciences Details
2.27.2 Shuwen Health Sciences Major Business
2.27.3 Shuwen Health Sciences At-home Genetic Testing Product and Solutions
2.27.4 Shuwen Health Sciences At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.27.5 Shuwen Health Sciences Recent Developments and Future Plans
2.28 Mapmygenome
2.28.1 Mapmygenome Details
2.28.2 Mapmygenome Major Business
2.28.3 Mapmygenome At-home Genetic Testing Product and Solutions
2.28.4 Mapmygenome At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.28.5 Mapmygenome Recent Developments and Future Plans
2.29 Full Genomes
2.29.1 Full Genomes Details
2.29.2 Full Genomes Major Business
2.29.3 Full Genomes At-home Genetic Testing Product and Solutions
2.29.4 Full Genomes At-home Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.29.5 Full Genomes Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global At-home Genetic Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 At-home Genetic Testing Players Market Share
3.2.2 Top 10 At-home Genetic Testing Players Market Share
3.2.3 Market Competition Trend
3.3 At-home Genetic Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global At-home Genetic Testing Revenue and Market Share by Type (2016-2021)
4.2 Global At-home Genetic Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global At-home Genetic Testing Revenue Market Share by Application (2016-2021)
5.2 At-home Genetic Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America At-home Genetic Testing Revenue by Type (2016-2026)
6.2 North America At-home Genetic Testing Revenue by Application (2016-2026)
6.3 North America At-home Genetic Testing Market Size by Country
6.3.1 North America At-home Genetic Testing Revenue by Country (2016-2026)
6.3.2 United States At-home Genetic Testing Market Size and Forecast (2016-2026)
6.3.3 Canada At-home Genetic Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico At-home Genetic Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe At-home Genetic Testing Revenue by Type (2016-2026)
7.2 Europe At-home Genetic Testing Revenue by Application (2016-2026)
7.3 Europe At-home Genetic Testing Market Size by Country
7.3.1 Europe At-home Genetic Testing Revenue by Country (2016-2026)
7.3.2 Germany At-home Genetic Testing Market Size and Forecast (2016-2026)
7.3.3 France At-home Genetic Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom At-home Genetic Testing Market Size and Forecast (2016-2026)
7.3.5 Russia At-home Genetic Testing Market Size and Forecast (2016-2026)
7.3.6 Italy At-home Genetic Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific At-home Genetic Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific At-home Genetic Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific At-home Genetic Testing Market Size by Region
8.3.1 Asia-Pacific At-home Genetic Testing Revenue by Region (2016-2026)
8.3.2 China At-home Genetic Testing Market Size and Forecast (2016-2026)
8.3.3 Japan At-home Genetic Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea At-home Genetic Testing Market Size and Forecast (2016-2026)
8.3.5 India At-home Genetic Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia At-home Genetic Testing Market Size and Forecast (2016-2026)
8.3.7 Australia At-home Genetic Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America At-home Genetic Testing Revenue by Type (2016-2026)
9.2 South America At-home Genetic Testing Revenue by Application (2016-2026)
9.3 South America At-home Genetic Testing Market Size by Country
9.3.1 South America At-home Genetic Testing Revenue by Country (2016-2026)
9.3.2 Brazil At-home Genetic Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina At-home Genetic Testing Market Size and Forecast (2016-2026)
....contiued
Contact Details :
+44 203 500 2763
+1 62 825 80070
971 0503084105
The latest trending report Global Carcinoembryonic Antigen (CEA) Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Carcinoembryonic Antigen (CEA) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 2103.4 million by 2025, from USD 1804.5 million in 2019.The Carcinoembryonic Antigen (CEA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/31935-carcinoembryonic-antigen-cea-market-analysis-reportThe major players covered in Carcinoembryonic Antigen (CEA) are:Roche DiagnosticsAbbott DiagnosticsQuest DiagnosticsBy Type, Carcinoembryonic Antigen (CEA) market has been segmented into:CD66aCD66bCD66cCD66dCD66eCD66fBy Application, Carcinoembryonic Antigen (CEA) has been segmented into:Colorectal CancerPancreatic CancerOvarian CancerBreast CancerThyroid CancerOthersThe report offers in-depth assessment of the growth and other aspects of the Carcinoembryonic Antigen (CEA) market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)South America (Brazil, Argentina, Colombia)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Carcinoembryonic Antigen (CEA) Market @ https://www.decisiondatabases.com/contact/download-sample-31935There are 14 Chapters to deeply display the global Carcinoembryonic Antigen (CEA) market.1 Carcinoembryonic Antigen (CEA) Market Overview2 Company Profiles3 Global Carcinoembryonic Antigen (CEA) Market Competition, by Players4 Global Carcinoembryonic Antigen (CEA) Market Size by Regions5 North America Carcinoembryonic Antigen (CEA) Revenue by Countries6 Europe Carcinoembryonic Antigen (CEA) Revenue by Countries7 Asia-Pacific Carcinoembryonic Antigen (CEA) Revenue by Countries8 South America Carcinoembryonic Antigen (CEA) Revenue by Countries9 Middle East and Africa Revenue Carcinoembryonic Antigen (CEA) by Countries10 Global Carcinoembryonic Antigen (CEA) Market Segment by Type11 Global Carcinoembryonic Antigen (CEA) Market Segment by Application12 Global Carcinoembryonic Antigen (CEA) Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global Carcinoembryonic Antigen (CEA) Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-31935Other Reports by DecisionDatabases.com:Global Rapid Tests Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global Anti-microbial/Anti-fungal Tests Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global Hepatitis Viruses Rapid Tests Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
According to the new market research report “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.Browse and in-depth TOC on “Esoteric Testing Market”134 – Tables47 – Figures244 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708The rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the market.In 2020, infectious diseases accounted for the largest share of the Esoteric Testing Market.
The genetic testing segment is expected to grow at the highest CAGR during the forecast period.Based on the type, the market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.
In 2020, the infectious disease testing segment accounted the largest share of the Esoteric Testing Market.
The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.
The genetic testing segment is expected to register the highest CAGR during the forecast period.
The fastest growth of the genetic testing segment is attributed to the advancements in the sequencing technologies such as NGS and increasing awareness.CLIA segment account for the largest share of the market in 2020.Based on technology, Esoteric Testing Market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies.
The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market Research.
The report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player’s in cost-effective treatments are the key factors responsible for market growth.
Moreover, government-sponsored schemes are also expected to positively impact the market.
In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.
The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region.
The global cervical dysplasia market size is expected to reach USD 936.4 million by 2028 according to a new study by Polaris Market Research.
The report “Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic Tests, {HPV Test, Pap Smear Test, Biopsy Test}, Diagnostic Devices, Colposcope); By End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors.
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/cervical-dysplasia-market/request-for-sample Moreover, Cervical Awareness Month was introduced by the U.S. Congress, in 2019, to declare the month of January dedicated to the patients suffering from cervical cancer in the market.
For instance, in January 2020, both Japan pharmaceutical giants ASKA Pharmaceutical and KinoPharma entered into a collaborative agreement for the development and commercialization of drug candidates for cervical dysplasia in the market, which is under preclinical phase under KinoPharma.
Under the agreement, ASKA would obtain exclusive rights to sell the drug in the Japanese market and will help later in co-developing potential drug candidates and KinoPharma in return will receive upfront payments for the exclusive licensing.
The global revenue cycle management market size is expected to reach USD 613.45 billion by 2028 according to a new study by Polaris Market Research.
The report “Revenue Cycle Management Market Share, Size, Trends, Industry Analysis Report, By Product Type (Software, Services); By Type (Integrated, Standalone); By Delivery Mode (On-premise, Web-based, Cloud based); By End-Use (Physician Offices, Hospitals, Diagnostic Laboratories); By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Major advantages in outsourcing revenue cycle management services are the availability of skilled professionals, compliance, regulations, and cost-effective services.
Owing to such advantages, there is an increasing trend of outsourcing revenue cycle management services over the past few years.
For instance, according to the research done by the Med-USA, around two-thirds of the healthcare facilities are using outsourcing services for their daily workflow management.
Hence, increasing adoption of such systems is likely to garner high revenue generation during the revenue cycle management study period.
